1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc.

RARE
Ultragenyx Pharmaceutical Inc.US flagNASDAQ Global Select
27.95
USD
-0.67
- -
2.75BMarket Cap

Income Statement (USD)

APIChatGPT
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2011
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
3
51
104
271
351
363
434
560
673
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
3
51
104
271
351
363
434
560
673
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
1
9
6
16
28
45
77
109
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
1
9
6
16
28
45
77
109
Gross Profit
- -
- -
- -
- -
- -
- -
3
50
95
265
335
335
389
483
564
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
7
16
32
57
148
248
332
422
519
595
717
984
958
1,019
1,099
+ Selling, General & Admin
2
3
4
11
33
65
100
128
162
183
220
278
310
321
349
+ Research & Development
5
13
28
46
115
183
232
294
357
412
497
706
648
698
750
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-7
-16
-32
-57
-148
-248
-329
-371
-424
-330
-382
-649
-569
-536
-535
- Non-Operating (Income) Loss
- -
- -
3
3
-2
-2
-11
-174
-25
-145
71
53
40
31
36
+ Interest Expense, Net
- -
- -
- -
-1
-2
-4
-4
-10
-12
26
27
32
39
26
37
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
1
33
29
43
66
63
62
- Interest Income
- -
- -
- -
1
2
4
4
10
13
7
2
11
27
37
25
+ Other Non-Op (Income) Loss
- -
- -
3
4
- -
2
-7
-165
-13
-171
44
21
1
5
-1
Pretax Income
-7
-16
-35
-60
-146
-246
-318
-197
-399
-185
-453
-702
-609
-567
-571
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
-16
1
3
1
1
6
-2
2
4
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-7
-16
-35
-60
-146
-246
-302
-198
-403
-187
-454
-707
-607
-569
-575
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-7
-16
-35
-60
-146
-246
-302
-198
-403
-187
-454
-707
-607
-569
-575
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-7
-16
-35
-60
-146
-246
-302
-198
-403
-187
-454
-707
-607
-569
-575
- Preferred Dividends
1
3
15
5
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-7
-20
-50
-65
-146
-246
-302
-198
-403
-187
-454
-707
-607
-569
-575
EBIT
-7
-16
-32
-57
-148
-248
-329
-371
-424
-330
-382
-649
-569
-536
-535
EBITDA
-7
-16
-32
-56
-146
-245
-323
-352
-416
-318
-368
-631
-543
-500
-500
EBITDA Margin (%)
- -
- -
- -
- -
- -
-183,896.99
-12,370.48
-683.24
-400.75
-117.28
-104.86
-173.59
-125.12
-89.29
-74.29
EBITA
-7
-16
-32
-57
-148
-248
-329
-371
-424
-330
-382
-649
-569
-536
-535
Gross Margin (%)
- -
- -
- -
- -
- -
100
99.96
97.77
91.31
97.74
95.44
92.21
89.63
86.25
83.8
Operating Margin (%)
- -
- -
- -
- -
- -
-186,471.43
-12,593.49
-721.18
-408.98
-121.8
-108.63
-178.6
-131.11
-95.71
-79.49
Profit Margin (%)
- -
- -
- -
- -
- -
-184,867.67
-11,567.34
-383.75
-388.31
-68.84
-129.2
-194.71
-139.86
-101.61
-85.44
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
0.15
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
1
1
3
6
20
9
12
13
18
26
36
35
Basic Weighted Avg Shares
23
23
29
29
37
40
42
50
57
61
68
70
74
91
99
Basic EPS, GAAP
-0.32
-0.85
-1.73
-2.25
-3.96
-6.21
-7.12
-3.97
-7.12
-3.07
-6.7
-10.12
-8.25
-6.28
-5.83
Basic EPS from Cont Ops
-0.3
-0.71
-1.21
-2.08
-3.96
-6.21
-7.12
-3.97
-7.12
-3.07
-6.7
-10.12
-8.25
-6.28
-5.83
Diluted Weighted Avg Shares
23
23
29
29
37
40
42
50
57
61
68
70
74
91
99
Diluted EPS, GAAP
-0.32
-0.85
-1.73
-2.25
-3.96
-6.21
-7.12
-3.97
-7.12
-3.07
-6.7
-10.12
-8.25
-6.28
-5.83
Diluted EPS from Cont Ops
-0.3
-0.71
-1.21
-2.08
-3.96
-6.21
-7.12
-3.97
-7.12
-3.07
-6.7
-10.12
-8.25
-6.28
-5.83

Balance Sheet (USD)

APIChatGPT
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2011
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
11
86
55
193
450
402
270
522
851
1,295
857
884
732
817
951
+ Cash, Cash Equivalents & STI
11
86
53
187
437
380
234
460
755
1,202
740
748
577
610
680
+ Cash & Cash Equivalents
11
86
7
24
94
161
100
113
434
714
308
133
214
174
421
+ ST Investments
- -
- -
46
163
343
219
134
346
322
488
433
615
364
436
259
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
5
13
33
23
28
40
73
122
158
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
5
13
33
23
28
40
73
122
158
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
1
7
12
13
16
27
34
45
52
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
1
5
8
7
11
17
19
22
27
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
2
3
6
6
9
15
23
25
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
2
6
13
22
29
43
51
58
72
69
48
40
61
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
1
2
4
5
109
139
221
197
284
464
666
662
759
686
- -
+ Property, Plant & Equip, Net
1
1
1
3
7
17
22
20
75
114
176
260
291
266
244
+ Property, Plant & Equip
1
2
2
5
10
23
33
38
101
151
226
323
374
378
380
- Accumulated Depreciation
- -
- -
1
1
3
6
11
18
26
37
50
63
83
112
136
+ LT Investments & Receivables
- -
- -
- -
- -
99
118
10
- -
33
166
294
149
200
135
57
+ LT Investments
- -
- -
- -
- -
99
118
10
- -
33
166
294
149
200
135
57
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
1
3
2
3
4
189
177
177
184
196
253
268
285
-301
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
186
174
173
176
175
205
211
222
220
+ Goodwill
- -
- -
- -
- -
- -
- -
44
44
44
44
44
44
44
44
44
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
142
129
129
131
131
160
166
178
176
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
1
3
2
3
4
3
4
3
9
21
48
58
63
-521
Total Assets
12
88
60
198
560
541
491
720
1,135
1,760
1,522
1,545
1,491
1,503
1,532
+ Payables & Accruals
1
3
6
12
28
60
65
75
96
121
163
248
222
247
239
+ Accounts Payable
- -
1
1
5
3
5
9
12
13
13
17
43
42
39
31
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
2
4
8
25
55
56
62
83
108
146
205
179
208
208
+ ST Debt
- -
- -
- -
- -
- -
- -
- -
- -
7
9
11
12
13
10
12
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
7
9
11
12
13
10
12
+ Other ST Liabilities
- -
- -
- -
- -
- -
- -
6
- -
- -
59
8
1
46
87
133
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
6
- -
- -
59
8
1
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
46
87
133
Total Current Liabilities
1
3
6
13
28
60
71
75
103
190
181
261
280
344
384
+ LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
30
39
31
20
31
30
24
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
30
39
31
20
31
30
24
+ Other LT Liabilities
- -
1
4
1
1
6
36
36
349
376
388
912
905
867
1,197
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
31
31
33
41
35
32
30
30
30
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
1
4
1
1
6
5
5
315
336
353
880
875
837
1,167
Total Noncurrent Liabilities
- -
1
4
1
1
6
36
36
378
416
418
932
935
897
1,221
Total Liabilities
1
4
10
13
28
67
107
111
482
605
600
1,193
1,216
1,241
1,605
+ Preferred Equity and Hybrid Capital
19
111
125
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
- -
324
817
1,004
1,222
1,640
2,087
2,773
2,998
3,140
3,662
4,213
4,451
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
- -
324
817
1,004
1,222
1,640
2,087
2,773
2,997
3,140
3,662
4,213
4,451
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
8
+ Retained Earnings
-8
-27
-75
-139
-285
-531
-833
-1,030
-1,433
-1,620
-2,074
-2,781
-3,388
-3,957
-4,532
+ Other Equity
- -
- -
- -
- -
-1
1
-6
-1
- -
1
-1
-7
1
-1
1
Equity Before Minority Interest
11
84
50
185
531
474
383
609
654
1,154
923
352
275
255
-80
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
7
7
Total Equity
11
84
50
185
531
474
383
609
654
1,154
923
352
275
262
-73
Total Liabilities & Equity
12
88
60
198
560
541
491
720
1,135
1,760
1,522
1,545
1,491
1,503
1,532
Shares Outstanding
29
29
29
32
39
41
44
51
58
67
69
70
82
92
96
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
37
48
42
32
43
40
36
Net Debt
-11
-86
-7
-24
-94
-161
-100
-113
-434
-714
-308
-133
-214
-174
-421
Net Debt to Equity
-100.02
-102.19
-14.82
-13.15
-17.62
-33.99
-26.21
-18.63
-66.32
-61.81
-33.34
-37.72
-77.55
-66.41
576.71
Tangible Common Equity Ratio
-65.64
-30.63
-125.44
93.42
94.91
87.67
64.8
79.73
49.93
61.8
55.48
11.04
5.06
3.12
-22.33
Current Ratio
10.96
27.12
9.33
15.45
16.13
6.67
3.8
6.99
8.24
6.83
4.72
3.38
2.61
2.38
2.48
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
135,082.96
791.04
117.05
153.11
74.69
27.93
-4.33
82.68
128.21

Cash Flow Statement (USD)

APIChatGPT
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2011
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-7
-16
-35
-60
-146
-246
-302
-198
-403
-187
-454
-707
-607
-569
-575
+ Depreciation & Amortization
- -
- -
- -
1
1
3
6
20
9
12
13
18
26
36
35
+ Non-Cash Items
1
1
5
12
31
55
63
-88
66
-63
165
249
122
105
97
+ Stock-Based Compensation
- -
1
1
5
25
48
68
80
82
86
105
130
135
158
153
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
4
7
6
7
-5
-168
-16
-148
60
118
-13
-53
-56
+ Chg in Non-Cash Work Cap
- -
2
-2
2
8
26
-20
-25
-17
105
-63
60
-16
14
-23
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
-5
-8
-20
10
-5
-12
-23
-34
-31
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
-1
-5
-4
-1
-3
-10
-7
-11
-6
+ (Inc) Dec in Prepaid Assets
- -
- -
-2
-4
-7
-7
3
-14
-8
3
-30
4
15
12
-10
+ Inc (Dec) in Accts Payable
1
2
3
7
15
35
-1
2
13
27
32
80
-1
47
24
+ Inc (Dec) in Other
- -
- -
-3
- -
- -
-1
-16
- -
2
67
-57
-2
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-6
-13
-31
-45
-106
-161
-254
-291
-345
-132
-339
-380
-475
-414
-466
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
-1
- -
-2
-5
-10
-3
-4
-25
-44
-73
-146
-47
-20
-21
+ Acq of Fixed Prod Assets
-1
-1
- -
-2
-5
-10
-3
-4
-25
-44
-73
-116
-44
-7
-6
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-30
-3
-13
-15
+ Cash (Repurchase) of Equity
- -
- -
- -
189
461
79
132
309
355
511
79
- -
387
392
86
+ Increase in Capital Stock
- -
- -
- -
189
461
79
132
309
355
511
79
- -
387
392
86
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-47
-121
-286
101
201
-200
12
-130
-121
-70
221
4
258
+ Dec in LT Investment
- -
- -
17
88
338
544
432
310
719
721
891
545
747
413
444
+ Inc in LT Investment
- -
- -
-64
-209
-624
-442
-230
-510
-707
-850
-1,012
-615
-526
-409
-186
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
-143
- -
- -
- -
- -
-75
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
-143
- -
- -
- -
- -
-75
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
-2
- -
- -
170
- -
-6
-1
-1
-6
-2
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-1
-1
-48
-123
-292
91
55
-33
-13
-179
-195
-292
168
-18
236
+ Dividends Paid
- -
- -
- -
-4
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
2
- -
- -
- -
- -
- -
-5
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
-5
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
15
89
- -
1
6
59
9
28
324
89
40
501
1
7
392
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
17
89
- -
185
468
139
136
337
679
600
119
501
388
399
478
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
1
- -
- -
1
-1
-1
- -
-2
4
Net Changes in Cash
11
76
-79
17
69
69
-62
13
321
289
-416
-171
81
-33
248
EBITDA
-7
-16
-32
-56
-146
-245
-323
-352
-416
-318
-368
-631
-543
-500
-500
EBITDA Margin (%)
- -
- -
- -
- -
- -
-183,896.99
-12,370.48
-683.24
-400.75
-117.28
-104.86
-173.59
-125.12
-89.29
-74.29
Free Cash Flow
-6
-14
-32
-47
-111
-171
-257
-295
-370
-176
-412
-527
-522
-434
-487
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
143
- -
- -
- -
- -
75
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
76
-33
-177
-111
-171
-262
-295
-370
-176
-412
-497
-519
-421
-472
Free Cash Flow per Basic Share
-0.28
-0.59
-1.09
-1.63
-3.02
-4.32
-6.05
-5.92
-6.54
-2.89
-6.07
-7.53
-7.1
-4.79
-4.94
Price/Free Cash Flow
- -
- -
- -
-29.7
-40.85
-18.46
-7.84
-7.55
-7.54
-95.37
-21.46
-13.82
-8.22
-9.67
-5.1
Cash Flow to Net Income
0.85
0.77
0.89
0.75
0.73
0.65
0.84
1.47
0.86
0.71
0.75
0.54
0.78
0.73
0.81
Capital Expenditures
-1
-1
- -
-2
-5
-10
-3
-4
-25
-44
-73
-146
-47
-20
-21